<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>1409</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>10395333</PubmedId>
            <Abstract>Graft-versus-host disease (GvHD) is a chief complication of allogeneic bone marrow transplantation. In HLA-identical bone marrow transplantation, GvHD may be induced by disparities in minor histocompatibility antigens (mHags) between the donor and the recipient, with the antigen being present in the recipient and not in the donor. Cytotoxic T lymphocytes (CTLs) specific for mHags of the recipients can be isolated from the blood of recipients with severe GvHD (ref. 3). A retrospective study demonstrated an association between mismatch for mHags HA-1, -2, -4 and -5 and the occurrence of GvHD in adult recipients of bone marrow from HLA genotypically identical donors. Tetrameric HLA-peptide complexes have been used to visualize and quantitate antigen-specific CTLs in HIV-infected individuals and during Epstein-Barr virus and lymphocytic choriomeningitis virus infections. Here we show the direct ex vivo visualization of mHag-specific CTLs during GvHD using tetrameric HLA-class and I-mHag HA-1 and HY peptide complexes. In the peripheral blood of 17 HA-1 or HY mismatched marrow recipients, HA-1- and HY-specific CTLs were detected as early as 14 days after bone marrow transplantation. The tetrameric complexes demonstrated a significant increase in HA-1- and HY-specific CTLs during acute and chronic GvHD, which decreased after successful GvHD treatment. HLA class I-mHag peptide tetramers may serve as clinical tools for the diagnosis and monitoring of GvHD patients.</Abstract>
            <ArticleYear>1999</ArticleYear>
            <ArticlePages>839-42</ArticlePages>
            <ArticleTitle>Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Mutis</LastName>
                    <ForeName>T</ForeName>
                </Author>
                <Author>
                    <LastName>Gillespie</LastName>
                    <ForeName>G</ForeName>
                </Author>
                <Author>
                    <LastName>Schrama</LastName>
                    <ForeName>E</ForeName>
                </Author>
                <Author>
                    <LastName>Falkenburg</LastName>
                    <ForeName>J H</ForeName>
                </Author>
                <Author>
                    <LastName>Moss</LastName>
                    <ForeName>P</ForeName>
                </Author>
                <Author>
                    <LastName>Goulmy</LastName>
                    <ForeName>E</ForeName>
                </Author>
            </Authors>
            <Affiliations>The Department of Immunohematology and Blood Bank, Leiden University Medical Center, The Netherlands. Mutis@rullf2.leidenuniv.nl</Affiliations>
            <ArticleChemicalList>Histocompatibility Antigens Class I;Macromolecular Substances;Minor Histocompatibility Antigens</ArticleChemicalList>
            <ArticleMeshHeadingsList>Adult; Bone Marrow Transplantation(immunology); Graft vs Host Disease(immunology); Histocompatibility Antigens Class I(genetics; immunology); Histocompatibility Testing; Humans; Macromolecular Substances; Minor Histocompatibility Antigens(genetics; immunology); Monitoring, Immunologic; Retrospective Studies; T-Lymphocytes, Cytotoxic(immunology); Transplantation, Homologous</ArticleMeshHeadingsList>
            <Journal>
                <Volume>5</Volume>
                <Issue>7</Issue>
                <Title>Nature medicine</Title>
                <Issn>1078-8956</Issn>
                <MedlineTa>Nat Med</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>HA-1 peptide</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>VLHDDLLEA</LinearSequence>
                        <StartingPosition>137</StartingPosition>
                        <EndingPosition>145</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAH65223.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9606</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Reference cited</LocationOfData>
                <EpitopeId>136896</EpitopeId>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The epitope sequence is from the cited reference: den Haan et al. (1998) Science 279: 1054-1057 [PMID: 9461441].</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 1, 2 and 3</LocationOfData>
                        <TCellId>1813531</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>No immunization</InVivoProcessType>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AdoptiveTransfer>
                            <RecipientOrganism>
                                <OrganismId>9606</OrganismId>
                                <MhcAlleleTypesPresent>
                                    <MhcAlleleId>235</MhcAlleleId>
                                </MhcAlleleTypesPresent>
                            </RecipientOrganism>
                            <TransferredEffectorCell>
                                <TransferredEffectorCellTissueType>Blood</TransferredEffectorCellTissueType>
                                <TransferredEffectorCellType>Stem cell</TransferredEffectorCellType>
                                <TransferredEffectorCellCultureConditions>Direct Ex Vivo</TransferredEffectorCellCultureConditions>
                            </TransferredEffectorCell>
                            <InVivoProcessInRecipient>
                                <InVivoProcessType>Occurrence of disease</InVivoProcessType>
                                <DiseaseState>ONTIE:0003422</DiseaseState>
                                <DiseaseStage>Acute/Recent onset</DiseaseStage>
                            </InVivoProcessInRecipient>
                            <AdoptiveTransferComments>The HLA-A2-restricted HA-1 specific CTL clone was derived from PBMCs of an HLA-A2- and HA-1-positive patient who received a bone marrow transplant from an HLA-A2-positive but HA-1-negative donor. PBMCs were also obtained from additional patients who received bone marrow transplants from HLA-identical but HA-1 mismatched donors.</AdoptiveTransferComments>
                        </AdoptiveTransfer>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <MhcAllele>
                            <MhcAlleleId>143</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Single MHC type present</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>VLHDDLLEA</LinearSequence>
                                        <StartingPosition>137</StartingPosition>
                                        <EndingPosition>145</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAH65223.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>47</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope specific CTL clone stained specifically with epitope/HLA-A2 tetramers. PBMCs from recipients of bone marrow transplants from HLA-identical but HA-1 mismatched donors were negative before BMT, but showed increasing epitope/HLA-A2 tetramer staining as acute followed by chronic GvHD developed. The frequency of tetramer stained cells correlated with the patient GvHD status. PBMCs from healthy individuals negative for HLA-A2,  GvHD patients negative for HLA-A2, and  GvHD patients positive for HLA-A2 who received mHAg-matched bone marrow transplants showed essentially no staining (0.01-0.3%) with epitope/HLA-A2 tetramers.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>1813578</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>No immunization</InVivoProcessType>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AdoptiveTransfer>
                            <RecipientOrganism>
                                <OrganismId>9606</OrganismId>
                                <MhcAlleleTypesPresent>
                                    <MhcAlleleId>235</MhcAlleleId>
                                </MhcAlleleTypesPresent>
                            </RecipientOrganism>
                            <TransferredEffectorCell>
                                <TransferredEffectorCellTissueType>Blood</TransferredEffectorCellTissueType>
                                <TransferredEffectorCellType>Stem cell</TransferredEffectorCellType>
                                <TransferredEffectorCellCultureConditions>Direct Ex Vivo</TransferredEffectorCellCultureConditions>
                            </TransferredEffectorCell>
                            <InVivoProcessInRecipient>
                                <InVivoProcessType>Occurrence of disease</InVivoProcessType>
                                <DiseaseState>ONTIE:0003422</DiseaseState>
                                <DiseaseStage>Acute/Recent onset</DiseaseStage>
                            </InVivoProcessInRecipient>
                            <AdoptiveTransferComments>PBMCs were obtained from patients who received bone marrow transplants from HLA-identical but HA-1 mismatched donors. Epitope/HLA-A2 tetramer positive CD8+ T lymphocytes were sorted from PBMC taken at 45 days post BMT when the patient was undergoing acute GvHD. PBMCs were restimulated in vitro with the recipient's pre-BMT PBMC to obtain CTL lines.</AdoptiveTransferComments>
                        </AdoptiveTransfer>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>143</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Single MHC type present</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>AAH65223.1</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Epitope/HLA-A2 tetramer sorted CD8+ T lymphocytes from a patient undergoing acute GvHD lysed HA-1 positive B-LCL.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>1813575</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>No immunization</InVivoProcessType>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AdoptiveTransfer>
                            <RecipientOrganism>
                                <OrganismId>9606</OrganismId>
                                <MhcAlleleTypesPresent>
                                    <MhcAlleleId>235</MhcAlleleId>
                                </MhcAlleleTypesPresent>
                            </RecipientOrganism>
                            <TransferredEffectorCell>
                                <TransferredEffectorCellTissueType>Blood</TransferredEffectorCellTissueType>
                                <TransferredEffectorCellType>Stem cell</TransferredEffectorCellType>
                                <TransferredEffectorCellCultureConditions>Direct Ex Vivo</TransferredEffectorCellCultureConditions>
                            </TransferredEffectorCell>
                            <InVivoProcessInRecipient>
                                <InVivoProcessType>Occurrence of disease</InVivoProcessType>
                                <DiseaseState>ONTIE:0003422</DiseaseState>
                                <DiseaseStage>Acute/Recent onset</DiseaseStage>
                            </InVivoProcessInRecipient>
                            <AdoptiveTransferComments>PBMCs were obtained from patients who received bone marrow transplants from HLA-identical but HA-1 mismatched donors. Epitope/HLA-A2 tetramer positive CD8+ T lymphocytes were sorted from PBMC taken at 45 days post BMT when the patient was undergoing acute GvHD. PBMCs were restimulated in vitro with the recipient's pre-BMT PBMC to obtain CTL lines.</AdoptiveTransferComments>
                        </AdoptiveTransfer>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>143</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Single MHC type present</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>VLHDDLLEA</LinearSequence>
                                        <StartingPosition>137</StartingPosition>
                                        <EndingPosition>145</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAH65223.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Epitope/HLA-A2 tetramer sorted CD8+ T lymphocytes from a patient undergoing acute GvHD lysed HA-1 negative B-LCL pulsed with the epitope.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HLA-A2-restricted H-Y peptide</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>FIDSYICQV</LinearSequence>
                        <StartingPosition>311</StartingPosition>
                        <EndingPosition>319</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAC50806.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9606</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Reference cited</LocationOfData>
                <EpitopeId>137402</EpitopeId>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The epitope sequence is from the cited reference: Meadows et al. (1998) Immunity 6(3): 273-281 [PMID: 9075928].</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 1</LocationOfData>
                        <TCellId>1813535</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <Sex>M</Sex>
                                <MhcAlleleTypesPresent>
                                    <MhcAlleleId>235</MhcAlleleId>
                                </MhcAlleleTypesPresent>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>No immunization</InVivoProcessType>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AdoptiveTransfer>
                            <RecipientOrganism>
                                <OrganismId>9606</OrganismId>
                                <Sex>M</Sex>
                                <MhcAlleleTypesPresent>
                                    <MhcAlleleId>235</MhcAlleleId>
                                </MhcAlleleTypesPresent>
                            </RecipientOrganism>
                            <TransferredEffectorCell>
                                <TransferredEffectorCellTissueType>Blood</TransferredEffectorCellTissueType>
                                <TransferredEffectorCellType>Stem cell</TransferredEffectorCellType>
                                <TransferredEffectorCellCultureConditions>Direct Ex Vivo</TransferredEffectorCellCultureConditions>
                            </TransferredEffectorCell>
                            <InVivoProcessInRecipient>
                                <InVivoProcessType>Occurrence of disease</InVivoProcessType>
                                <DiseaseState>ONTIE:0003422</DiseaseState>
                                <DiseaseStage>Unknown</DiseaseStage>
                            </InVivoProcessInRecipient>
                            <AdoptiveTransferComments>PBMCs were obtained from GvHD patients positive for HLA-A2 who received bone marrow transplant from minor histocompatibility Ag matched donors. PBMCs of were also obtained from GvHD patients or healthy individuals negative for HLA-A2.</AdoptiveTransferComments>
                        </AdoptiveTransfer>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <MhcAllele>
                            <MhcAlleleId>143</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Single MHC type present</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>FIDSYICQV</LinearSequence>
                                        <StartingPosition>311</StartingPosition>
                                        <EndingPosition>319</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAC50806.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>47</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>PBMCs from healthy individuals negative for HLA-A2,  GvHD patients negative for HLA-A2, and  GvHD patients positive for HLA-A2 who received mHAg-matched bone marrow transplants showed essentially no staining (0.01-0.3%) with epitope/HLA-A2 tetramers.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 1, 2 and 3</LocationOfData>
                        <TCellId>1813534</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <Sex>F</Sex>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>No immunization</InVivoProcessType>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AdoptiveTransfer>
                            <RecipientOrganism>
                                <OrganismId>9606</OrganismId>
                                <Sex>M</Sex>
                                <MhcAlleleTypesPresent>
                                    <MhcAlleleId>235</MhcAlleleId>
                                </MhcAlleleTypesPresent>
                            </RecipientOrganism>
                            <TransferredEffectorCell>
                                <TransferredEffectorCellTissueType>Blood</TransferredEffectorCellTissueType>
                                <TransferredEffectorCellType>Stem cell</TransferredEffectorCellType>
                                <TransferredEffectorCellCultureConditions>Direct Ex Vivo</TransferredEffectorCellCultureConditions>
                            </TransferredEffectorCell>
                            <InVivoProcessInRecipient>
                                <InVivoProcessType>Occurrence of disease</InVivoProcessType>
                                <DiseaseState>ONTIE:0003422</DiseaseState>
                                <DiseaseStage>Acute/Recent onset</DiseaseStage>
                            </InVivoProcessInRecipient>
                            <AdoptiveTransferComments>The HLA-A2-restricted HY specific CTL clone was derived from PBMCs of an HLA-A2-positive male patient who received a bone marrow transplant from an HLA-A2-positive female donor. PBMCs were also obtained from additional male patients who received bone marrow transplants from HLA-identical female donors.</AdoptiveTransferComments>
                        </AdoptiveTransfer>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <MhcAllele>
                            <MhcAlleleId>143</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Single MHC type present</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>FIDSYICQV</LinearSequence>
                                        <StartingPosition>311</StartingPosition>
                                        <EndingPosition>319</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAC50806.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>47</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope specific CTL clone stained specifically with epitope/HLA-A2 tetramers. PBMCs from male recipients of bone marrow transplants from HLA-identical female donors were negative before BMT, but showed increasing epitope/HLA-A2 tetramer staining as acute followed by chronic GvHD developed. The frequency of tetramer stained cells correlated with the patient GvHD status.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HLA-B7-restricted H-Y peptide</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>SPSVDKARAEL</LinearSequence>
                        <StartingPosition>950</StartingPosition>
                        <EndingPosition>960</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAC50806.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9606</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Reference cited</LocationOfData>
                <EpitopeId>137455</EpitopeId>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The epitope sequence is from the cited reference: Wang et al. (1995) Science 269(5230): 1588-90 [PMID: 7667640].</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 1</LocationOfData>
                        <TCellId>1813537</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <Sex>M</Sex>
                                <MhcAlleleTypesPresent>
                                    <MhcAlleleId>300</MhcAlleleId>
                                </MhcAlleleTypesPresent>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>No immunization</InVivoProcessType>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AdoptiveTransfer>
                            <RecipientOrganism>
                                <OrganismId>9606</OrganismId>
                                <Sex>M</Sex>
                                <MhcAlleleTypesPresent>
                                    <MhcAlleleId>300</MhcAlleleId>
                                </MhcAlleleTypesPresent>
                            </RecipientOrganism>
                            <TransferredEffectorCell>
                                <TransferredEffectorCellTissueType>Blood</TransferredEffectorCellTissueType>
                                <TransferredEffectorCellType>Stem cell</TransferredEffectorCellType>
                                <TransferredEffectorCellCultureConditions>Direct Ex Vivo</TransferredEffectorCellCultureConditions>
                            </TransferredEffectorCell>
                            <InVivoProcessInRecipient>
                                <InVivoProcessType>Occurrence of disease</InVivoProcessType>
                                <DiseaseState>ONTIE:0003422</DiseaseState>
                                <DiseaseStage>Unknown</DiseaseStage>
                            </InVivoProcessInRecipient>
                            <AdoptiveTransferComments>PBMCs were obtained from GvHD patients positive for HLA-B7 who received bone marrow transplant from minor histocompatibility Ag matched donors. PBMCs of were also obtained from GvHD patients or healthy individuals negative for HLA-B7.</AdoptiveTransferComments>
                        </AdoptiveTransfer>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <MhcAllele>
                            <MhcAlleleId>300</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Single MHC type present</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SPSVDKARAEL</LinearSequence>
                                        <StartingPosition>950</StartingPosition>
                                        <EndingPosition>960</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAC50806.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>47</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>PBMCs from healthy individuals negative for HLA-B7,  GvHD patients negative for HLA-B7, and  GvHD patients positive for HLA-B7 who received mHAg-matched bone marrow transplants showed essentially no staining (0.01-0.3%) with epitope/HLA-B7 tetramers.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 1, 2 and 3</LocationOfData>
                        <TCellId>1813536</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <Sex>F</Sex>
                                <MhcAlleleTypesPresent>
                                    <MhcAlleleId>300</MhcAlleleId>
                                </MhcAlleleTypesPresent>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>No immunization</InVivoProcessType>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AdoptiveTransfer>
                            <RecipientOrganism>
                                <OrganismId>9606</OrganismId>
                                <Sex>M</Sex>
                                <MhcAlleleTypesPresent>
                                    <MhcAlleleId>300</MhcAlleleId>
                                </MhcAlleleTypesPresent>
                            </RecipientOrganism>
                            <TransferredEffectorCell>
                                <TransferredEffectorCellTissueType>Blood</TransferredEffectorCellTissueType>
                                <TransferredEffectorCellType>Stem cell</TransferredEffectorCellType>
                                <TransferredEffectorCellCultureConditions>Direct Ex Vivo</TransferredEffectorCellCultureConditions>
                            </TransferredEffectorCell>
                            <InVivoProcessInRecipient>
                                <InVivoProcessType>Occurrence of disease</InVivoProcessType>
                                <DiseaseState>ONTIE:0003422</DiseaseState>
                                <DiseaseStage>Unknown</DiseaseStage>
                            </InVivoProcessInRecipient>
                            <AdoptiveTransferComments>The HLA-B7-restricted HY specific CTL clone was derived from PBMCs of an HLA-B7-positive male patient who received a bone marrow transplant from an HLA-B7-positive female donor. PBMCs were also obtained from additional male patients who received bone marrow transplants from HLA-identical female donors.</AdoptiveTransferComments>
                        </AdoptiveTransfer>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <MhcAllele>
                            <MhcAlleleId>300</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Single MHC type present</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SPSVDKARAEL</LinearSequence>
                                        <StartingPosition>950</StartingPosition>
                                        <EndingPosition>960</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAC50806.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>47</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope specific CTL clone stained specifically with epitope/HLA-B7 tetramers. PBMCs from male recipients of bone marrow transplants from HLA-identical female donors were negative before BMT, but showed increasing epitope/HLA-B7 tetramer staining during acute GvHD, followed by reduced staining as the disease was controlled. The frequency of tetramer stained cells correlated with the patient GvHD status.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

